CURE (CURE) - Stock Discussion | I3investor

Global X S&P Biotech ETF

ASX (AUD): Global X S&P Biotech ETF (CURE)

Last Price

52.66

Today's Change

+0.36 (0.68%)

Day's Change

52.00 - 52.66

Trading Volume

886

Discussions

Be the first to like this. Showing 0 of 0 comments

Post a Comment

Latest Videos

MQ Market Updates - 13 November 2024

MQ Trader

Apps

Send individual or group chats with anyone on i3investor

Earn MQ Points while trading with MQ Trader

MQ Affiliate

Earn side income from Affiliate Program

Online learning and teaching marketplace

Top Articles

1

CEO Morning Brief

Australia raised Fair Trade in Trump Phone Call, Says PM Albanese

2

CEO Morning Brief

Australia Faces Economic Pain From Trump Win, Treasurer Warns

Hot Stocks Today >

1

Rio Tinto Group

1000

2

666

3

ASX Limited

666

4

Mineral Resources Limited

666

5

Bank of Queensland Limited

666

6

Macmahon Holdings Limited

666

7

Transurban Group

666

8

Perpetual Limited

666

9

Lynas Rare Earths Limited

666

10

Sheffield Resources Limited

666

Daily Stocks

0.013

-0.003

70,421,792

0.014

-0.003

69,966,341

0.057

+0.002

68,753,026

0.036

+0.002

67,377,582

0.003

-0.002

45,320,619

0.044

-0.002

31,798,236

0.402

-0.028

27,182,624

0.21

+0.01

25,259,974

3.19

+0.08

25,066,261

0.01

+0.003

22,309,624

More active Stocks

171.00

+9.45

973,081

458.00

+4.82

10,718

245.51

+4.03

119,464

152.84

+3.22

1,822,574

131.62

+1.87

501,313

229.77

+1.82

440,177

112.08

+1.82

5,261

131.54

+1.71

10,991

153.89

+1.66

31,752

55.00

+1.65

2,129,324

More gainer Stocks

0.25

-2.45

234,055

28.46

-1.79

825,136

284.05

-1.49

421,775

295.55

-1.38

103,227

106.14

-1.06

15,106

54.25

-1.04

58,731

36.66

-0.94

1,265,872

15.70

-0.84

5,486,226

62.76

-0.78

1,013,636

89.72

-0.62

16,802

More loser Stocks

Top Brokers >

Books Review >

Ride The Bull Short The Bear

CS Tan

4.9 / 5.0

This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....